Immatics N.V. (IMTX)
USD 6.73
(-6.27%)
USD 6.73
(-6.27%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 284.88 Million EUR | 46.35% |
| 2022 | 194.65 Million EUR | 29.27% |
| 2021 | 150.58 Million EUR | 0.13% |
| 2020 | 150.39 Million EUR | -14.12% |
| 2019 | 175.11 Million EUR | 148.42% |
| 2018 | 70.48 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 252.57 Million EUR | -11.34% |
| 2024 Q2 | 239.21 Million EUR | -5.34% |
| 2023 FY | 284.88 Million EUR | 46.35% |
| 2023 Q4 | 284.88 Million EUR | 50.18% |
| 2023 Q3 | 189.69 Million EUR | -1.19% |
| 2023 Q2 | 191.97 Million EUR | 7.61% |
| 2023 Q1 | 178.4 Million EUR | -8.35% |
| 2022 Q4 | 194.65 Million EUR | -19.31% |
| 2022 Q3 | 241.24 Million EUR | -0.87% |
| 2022 Q2 | 243.35 Million EUR | 46.43% |
| 2022 Q1 | 166.19 Million EUR | 10.37% |
| 2022 FY | 194.65 Million EUR | 29.27% |
| 2021 Q1 | 144.08 Million EUR | -4.19% |
| 2021 Q4 | 150.58 Million EUR | -8.04% |
| 2021 Q3 | 163.75 Million EUR | 16.91% |
| 2021 Q2 | 140.06 Million EUR | -2.79% |
| 2021 FY | 150.58 Million EUR | 0.13% |
| 2020 Q2 | 175.92 Million EUR | 2.4% |
| 2020 Q4 | 150.39 Million EUR | -6.81% |
| 2020 Q3 | 161.37 Million EUR | -8.27% |
| 2020 FY | 150.39 Million EUR | -14.12% |
| 2020 Q1 | 171.8 Million EUR | -1.89% |
| 2019 FY | 175.11 Million EUR | 148.42% |
| 2019 Q4 | 175.11 Million EUR | 300.0% |
| 2019 Q2 | 43.77 Million EUR | 0.0% |
| 2019 Q1 | 43.77 Million EUR | 0.0% |
| 2019 Q3 | 43.77 Million EUR | 0.0% |
| 2018 FY | 70.48 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -9263.576% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | 19.264% |
| IO Biotech, Inc. | 17.55 Million USD | -1522.699% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -3083.028% |
| Organovo Holdings, Inc. | 2.74 Million USD | -10266.849% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -5498.386% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -70431.161% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -482.198% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -946.28% |
| Savara Inc. | 37.19 Million USD | -665.974% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -1486.02% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -286.19% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -709.848% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -2480.517% |
| Soligenix, Inc. | 7.27 Million USD | -3815.942% |
| Aptose Biosciences Inc. | 15.8 Million USD | -1702.052% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -278.962% |
| Century Therapeutics, Inc. | 175.94 Million USD | -61.918% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -507.435% |
| Precision BioSciences, Inc. | 140.92 Million USD | -102.158% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | 28.288% |
| Kura Oncology, Inc. | 51.66 Million USD | -451.432% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -35088.523% |
| Dyadic International, Inc. | 2.34 Million USD | -12071.016% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -134.891% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -909.286% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -12.78% |
| Autolus Therapeutics plc | 263.9 Million USD | -7.947% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -1651.712% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -220.592% |
| GRI Bio, Inc. | 2.69 Million USD | -10462.885% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -816.281% |
| IGM Biosciences, Inc. | 220.17 Million USD | -29.387% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -11.074% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -969.3% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -8584.692% |
| Opthea Limited | 264.6 Million USD | -7.664% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -196.26% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -7.61% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -638.455% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -117.954% |
| Surrozen, Inc. | 8.14 Million USD | -3397.618% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -90667.481% |
| Cingulate Inc. | 10.36 Million USD | -2649.587% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -406.636% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | 42.391% |
| Acelyrin, Inc. | 86.35 Million USD | -229.903% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -124.803% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -2534.472% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -88.802% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -88.025% |
| ADMA Biologics, Inc. | 193.97 Million USD | -46.864% |
| PureTech Health plc | 125.58 Million USD | -126.847% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -4166.602% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -2595.695% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -935.517% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -57.577% |
| Synaptogenix, Inc. | 5.52 Million USD | -5052.05% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -4185.214% |
| ChromaDex Corporation | 26.5 Million USD | -974.698% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -7973.199% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -16110.432% |
| Exelixis, Inc. | 678.44 Million USD | 58.01% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -4.625% |
| Better Therapeutics, Inc. | 23.84 Million USD | -1094.87% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -73.659% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 52.057% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -245.591% |
| Seer, Inc. | 39.36 Million USD | -623.691% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -631.834% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -463.764% |
| Gritstone bio, Inc. | 125.91 Million USD | -126.241% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -1841.135% |
| Avid Bioservices, Inc. | 275.66 Million USD | -3.342% |
| Insmed Incorporated | 1.66 Billion USD | 82.857% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -1625.297% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -1981.094% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -106.735% |
| MediWound Ltd. | 27.18 Million USD | -947.857% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -118.786% |
| Fortress Biotech, Inc. | 165.93 Million USD | -71.678% |
| OmniAb, Inc. | 87.4 Million USD | -225.951% |
| Seres Therapeutics, Inc. | 403.45 Million USD | 29.39% |
| Zai Lab Limited | 240.17 Million USD | -18.613% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 54.785% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -311.464% |
| Veracyte, Inc. | 93.71 Million USD | -203.974% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -479.309% |
| FibroGen, Inc. | 585.72 Million USD | 51.363% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -1225.583% |
| ContextLogic Inc. | 206 Million USD | -38.292% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -6792.838% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -43521.416% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -298.546% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 96.279% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -25.591% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -3375.006% |
| ImmuCell Corporation | 18.81 Million USD | -1414.114% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 89.12% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -888.415% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -1841.135% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | 21.543% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 76.565% |
| Theravance Biopharma, Inc. | 169 Million USD | -68.565% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | 43.072% |
| Vaxxinity, Inc. | 30.94 Million USD | -820.634% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 70.706% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -4623.528% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -76605.87% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -9164.881% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -457.464% |
| Senti Biosciences, Inc. | 52.57 Million USD | -441.898% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -10826.095% |
| Apollomics, Inc. | 14.15 Million USD | -1912.867% |
| 89bio, Inc. | 59.96 Million USD | -375.095% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | 40.45% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -7972.829% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -983.445% |
| Ardelyx, Inc. | 130.76 Million USD | -117.861% |
| Pluri Inc. | 34.11 Million USD | -735.134% |
| Prothena Corporation plc | 135.01 Million USD | -110.996% |
| Pulmatrix, Inc. | 15.96 Million USD | -1684.633% |
| Celularity Inc. | 102.92 Million USD | -176.774% |
| MeiraGTx Holdings plc | 319.99 Million USD | 10.972% |
| Omeros Corporation | 403.25 Million USD | 29.354% |
| Ainos, Inc. | 7.39 Million USD | -3752.751% |
| Humacyte, Inc. | 114.67 Million USD | -148.42% |
| Mesoblast Limited | 188.79 Million USD | -50.892% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -5743.713% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -271.229% |
| Blueprint Medicines Corporation | 918.64 Million USD | 68.989% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -1532.369% |
| Summit Therapeutics Inc. | 125.25 Million USD | -127.437% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -14464.468% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -231.963% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -13.585% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -460.944% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 76.469% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -796.331% |
| Nutriband Inc. | 1.07 Million USD | -26304.299% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -2579.216% |
| Roivant Sciences Ltd. | 773.95 Million USD | 63.191% |
| Evogene Ltd. | 17.99 Million USD | -1483.552% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -295.783% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -40309.627% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 84.918% |
| BioLineRx Ltd. | 50.7 Million USD | -461.873% |
| Atai Life Sciences N.V. | 49.16 Million USD | -479.474% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -2941.326% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -67.471% |
| MediciNova, Inc. | 3.89 Million USD | -7220.496% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -1458.515% |
| MiMedx Group, Inc. | 96.33 Million USD | -195.734% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 89.533% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -813.051% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -385.449% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -10379.708% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1395.595% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -788.532% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -286.07% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -225.642% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -743.592% |
| Allakos Inc. | 74.79 Million USD | -280.893% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -1166.082% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -148.128% |
| BioAtla, Inc. | 48.98 Million USD | -481.556% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -118.126% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -1904.087% |
| Precigen, Inc. | 41.64 Million USD | -584.087% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -3229.141% |
| XOMA Corporation | 145.58 Million USD | -95.687% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -746.223% |
| Incyte Corporation | 1.59 Billion USD | 82.108% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -314.318% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -360.801% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -4211.624% |
| CRISPR Therapeutics AG | 346.76 Million USD | 17.847% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -533.562% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -9826.167% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -3392.037% |
| UroGen Pharma Ltd. | 243.52 Million USD | -16.983% |
| Sutro Biopharma, Inc. | 321.08 Million USD | 11.276% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -10215.952% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -4089.426% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -314.21% |
| Chimerix, Inc. | 19.74 Million USD | -1342.801% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -509.515% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -9441.594% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -16.022% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -6395.82% |
| Portage Biotech Inc. | 4.45 Million USD | -6301.82% |
| OncoCyte Corporation | 49.29 Million USD | -477.875% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -6786.498% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -34352.729% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -35622.472% |
| Purple Biotech Ltd. | 10 Million USD | -2747.386% |
| NextCure, Inc. | 14.99 Million USD | -1799.587% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -2199.649% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -17446.082% |
| Generation Bio Co. | 171.63 Million USD | -65.986% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -950.485% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | 18.039% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -2510.235% |
| NLS Pharmaceutics AG | 10.68 Million USD | -2567.374% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -2617.811% |
| Novavax, Inc. | 2.57 Billion USD | 88.925% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -79354.076% |
| Curis, Inc. | 57.61 Million USD | -394.482% |
| Daré Bioscience, Inc. | 26.32 Million USD | -981.969% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -19628.601% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -3602.627% |
| Bicycle Therapeutics plc | 224.41 Million USD | -26.946% |
| BeiGene, Ltd. | 2.23 Billion USD | 87.246% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -1238.11% |
| Alector, Inc. | 487.66 Million USD | 41.583% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -1239.104% |
| Erasca, Inc. | 78.61 Million USD | -262.393% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -1446.166% |
| Aura Biosciences, Inc. | 29.22 Million USD | -874.719% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -642.4% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -5427.345% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -43376.556% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -2289.54% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 84.927% |
| Histogen Inc. | 5.69 Million USD | -4900.544% |
| Fortress Biotech, Inc. | 165.93 Million USD | -71.678% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -122.927% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -199.632% |
| Galecto, Inc. | 5.89 Million USD | -4731.767% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -10787.146% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | 41.455% |
| Molecular Templates, Inc. | 31.17 Million USD | -813.93% |
| PDS Biotechnology Corporation | 33.25 Million USD | -756.55% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -239.055% |
| Amarin Corporation plc | 279.58 Million USD | -1.894% |
| TG Therapeutics, Inc. | 169.08 Million USD | -68.484% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -2157.198% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -681.438% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -412.054% |
| Onconetix, Inc. | 23.18 Million USD | -1128.948% |
| MacroGenics, Inc. | 154.2 Million USD | -84.739% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -959.667% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -6948.021% |
| Adagene Inc. | 45.16 Million USD | -530.695% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -7.75% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 61.773% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -147.807% |
| SciSparc Ltd. | 1.59 Million USD | -17760.878% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -5019.253% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -233.748% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -2366.502% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -581.028% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -12.736% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -209.731% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 92.967% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -2253.474% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -27802.155% |
| 2seventy bio, Inc. | 310.12 Million USD | 8.14% |
| Clene Inc. | 38.95 Million USD | -631.383% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -10.859% |
| GeoVax Labs, Inc. | 3.51 Million USD | -7993.484% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -4937.275% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -642.206% |
| Scopus BioPharma Inc. | 7.45 Million USD | -3721.632% |
| Absci Corporation | 58.3 Million USD | -388.613% |
| XBiotech Inc. | 8.39 Million USD | -3292.652% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -439.129% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -435.692% |
| Entera Bio Ltd. | 1.37 Million USD | -20558.521% |
| Trevena, Inc. | 48.26 Million USD | -490.28% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -17.185% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -292.577% |
| INmune Bio, Inc. | 18.86 Million USD | -1410.344% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -2238.989% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -1219.199% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -10259.309% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -663.92% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -7843.104% |
| Jaguar Health, Inc. | 45.86 Million USD | -521.116% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -470.561% |
| NexImmune, Inc. | 5.08 Million USD | -5503.226% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -1046.449% |
| Clearmind Medicine Inc. | 3.61 Million USD | -7791.423% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -7482.42% |
| Kronos Bio, Inc. | 54.2 Million USD | -425.601% |
| Innoviva, Inc. | 568.55 Million USD | 49.894% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 65.386% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 95.992% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -505.576% |
| Verastem, Inc. | 71.18 Million USD | -300.198% |
| ProKidney Corp. | 29.21 Million USD | -875.086% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1151.689% |
| Imunon, Inc. | 8.53 Million USD | -3239.587% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -1319.366% |
| Statera Biopharma, Inc. | 22.67 Million USD | -1156.286% |
| ImmunityBio, Inc. | 1.09 Billion USD | 73.873% |
| Korro Bio, Inc. | 51.75 Million USD | -450.473% |
| Travere Therapeutics, Inc. | 588.1 Million USD | 51.559% |
| Kineta, Inc. | 7.22 Million USD | -3844.628% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -239.039% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -688.426% |
| GT Biopharma, Inc. | 6.63 Million USD | -4194.904% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -653.414% |
| Celularity Inc. | 102.92 Million USD | -176.774% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -195.989% |
| CalciMedica, Inc. | 4.02 Million USD | -6972.517% |
| Cibus, Inc. | 206.11 Million USD | -38.213% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -118.573% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -84.816% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -570.703% |
| Kodiak Sciences Inc. | 213.59 Million USD | -33.377% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -2.552% |
| Annexon, Inc. | 47.11 Million USD | -504.612% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -218.157% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -195.606% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -1706.131% |
| Moderna, Inc. | 4.57 Billion USD | 93.769% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -1057.77% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 89.057% |
| Vor Biopharma Inc. | 59.1 Million USD | -382.0% |
| Eyenovia, Inc. | 19.78 Million USD | -1340.227% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -9080.825% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -60.872% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -128.811% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -25.253% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -3608.905% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | 10.189% |
| Immunocore Holdings plc | 228.15 Million USD | -24.861% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -90.608% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -222.114% |
| Alkermes plc | 933.53 Million USD | 69.484% |
| Arcellx, Inc. | 339.75 Million USD | 16.15% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -814.478% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -128.57% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -4938.574% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -2878.992% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -18838.521% |
| Moolec Science SA | 13.94 Million USD | -1942.838% |
| Biomea Fusion, Inc. | 30.69 Million USD | -828.254% |
| RenovoRx, Inc. | 4.46 Million USD | -6278.885% |
| Geron Corporation | 146.12 Million USD | -94.954% |
| Mereo BioPharma Group plc | 15.96 Million USD | -1684.745% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -360.719% |
| Royalty Pharma plc | 6.29 Billion USD | 95.476% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -616.213% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -96664.672% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -3338.93% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -11479.201% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -50.606% |
| Humacyte, Inc. | 114.67 Million USD | -148.42% |
| Structure Therapeutics Inc. | 29.05 Million USD | -880.624% |
| NLS Pharmaceutics AG | 10.68 Million USD | -2567.374% |
| Genelux Corporation | 8.42 Million USD | -3283.385% |
| ESSA Pharma Inc. | 3.49 Million USD | -8050.936% |
| aTyr Pharma, Inc. | 31.59 Million USD | -801.608% |
| Notable Labs, Ltd. | 4.42 Million USD | -6335.08% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -8731.403% |
| Mustang Bio, Inc. | 17.61 Million USD | -1516.897% |
| Immunovant, Inc. | 48.95 Million USD | -481.924% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1506.49% |
| Vericel Corporation | 127.7 Million USD | -123.077% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 82.729% |
| Akari Therapeutics, Plc | 4.58 Million USD | -6114.682% |
| Acasti Pharma Inc. | 11.55 Million USD | -2365.008% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -1160.104% |
| Vaxcyte, Inc. | 167.44 Million USD | -70.13% |
| Orgenesis Inc. | 35.53 Million USD | -701.691% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -938.31% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -4573.245% |
| GH Research PLC | 6.7 Million USD | -4151.321% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -1047.095% |
| PepGen Inc. | 34.63 Million USD | -722.618% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -2245.858% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -2236.086% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -3229.141% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -90667.481% |
| Silo Pharma, Inc. | 1.56 Million USD | -18053.728% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -21230.389% |
| Belite Bio, Inc | 4.21 Million USD | -6665.163% |
| Pharming Group N.V. | 244.07 Million USD | -16.72% |
| XOMA Corporation | 145.58 Million USD | -95.687% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -1413.232% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -4211.624% |
| Bionomics Limited | 10.15 Million USD | -2704.3% |
| Xencor, Inc. | 283.55 Million USD | -0.466% |
| Replimune Group, Inc. | 113.21 Million USD | -151.631% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -493.23% |
| Cassava Sciences, Inc. | 14.19 Million USD | -1906.911% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -175.168% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -157553.25% |
| Turnstone Biologics Corp. | 14.14 Million USD | -1913.578% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -881.84% |
| GeoVax Labs, Inc. | 3.51 Million USD | -7993.484% |
| MEI Pharma, Inc. | 8.35 Million USD | -3309.707% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -1135.926% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -18838.521% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -10151.205% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -4122.336% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -4823.626% |
| scPharmaceuticals Inc. | 57.26 Million USD | -397.513% |
| HilleVax, Inc. | 78.9 Million USD | -261.025% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -285.699% |
| Tharimmune, Inc. | 1.81 Million USD | -15595.525% |
| Genprex, Inc. | 3.25 Million USD | -8654.235% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1538.848% |
| Immunic, Inc. | 25.36 Million USD | -1022.994% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -5340.814% |
| Aptorum Group Limited | 5.25 Million USD | -5319.349% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -1128.783% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1538.848% |
| OKYO Pharma Limited | 7.42 Million USD | -3738.929% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -626.741% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -1268.37% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -4207.337% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 53.881% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -21826.725% |
| bluebird bio, Inc. | 424.62 Million USD | 32.91% |
| DBV Technologies S.A. | 42.8 Million USD | -565.61% |
| Compugen Ltd. | 55.77 Million USD | -410.768% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -43376.556% |
| Peak Bio, Inc. | 20.75 Million USD | -1272.698% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -3972.638% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -17102.959% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -2905.391% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -948.552% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -157.897% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -1568.899% |
| Benitec Biopharma Inc. | 4.96 Million USD | -5641.254% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -80.484% |
| Adicet Bio, Inc. | 37.12 Million USD | -667.46% |
| Prime Medicine, Inc. | 60.78 Million USD | -368.708% |
| Aditxt, Inc. | 28.53 Million USD | -898.477% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -21.116% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -157553.25% |
| Quantum-Si incorporated | 26.63 Million USD | -969.735% |
| GlycoMimetics, Inc. | 6.9 Million USD | -4027.47% |
| PolyPid Ltd. | 17.46 Million USD | -1530.874% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -153.455% |
| Invivyd, Inc. | 51.71 Million USD | -450.889% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -4279.247% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -95.299% |
| CorMedix Inc. | 11.91 Million USD | -2290.437% |
| Instil Bio, Inc. | 99.8 Million USD | -185.449% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -49.73% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -43.646% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -492.133% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -277.346% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1143.316% |
| AbCellera Biologics Inc. | 335.77 Million USD | 15.157% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -77.023% |
| Surrozen, Inc. | 8.14 Million USD | -3397.618% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -690.063% |
| Verona Pharma plc | 58.84 Million USD | -384.154% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -2066.395% |
| Vir Biotechnology, Inc. | 369.85 Million USD | 22.975% |
| Evaxion Biotech A/S | 17.61 Million USD | -1517.036% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -85.971% |
| Shattuck Labs, Inc. | 14.85 Million USD | -1817.229% |
| AlloVir, Inc. | 45.01 Million USD | -532.858% |
| BioVie Inc. | 9.7 Million USD | -2836.273% |
| Codexis, Inc. | 49.94 Million USD | -470.378% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -1881.23% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -70431.161% |
| Agenus Inc. | 462.29 Million USD | 38.377% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -82427.796% |
| Lantern Pharma Inc. | 2.73 Million USD | -10298.324% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -488.573% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -981.594% |
| Immix Biopharma, Inc. | 3.72 Million USD | -7554.423% |
| Celcuity Inc. | 51.45 Million USD | -453.704% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -2294.36% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -560.18% |
| IN8bio, Inc. | 8.77 Million USD | -3147.617% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -23719.482% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -4055.207% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -108.981% |
| Liquidia Corporation | 73.13 Million USD | -289.512% |
| Quantum-Si incorporated | 26.63 Million USD | -969.735% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -10379.708% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -672.517% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -4188.439% |
| United Therapeutics Corporation | 1.18 Billion USD | 75.902% |
| Solid Biosciences Inc. | 38.45 Million USD | -640.759% |
| Immuneering Corporation | 12 Million USD | -2272.357% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1143.316% |
| uniQure N.V. | 624.01 Million USD | 54.347% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -1082.128% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -12056.199% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -67.396% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -2814.682% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -976.526% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -20803.45% |
| Cue Biopharma, Inc. | 24.44 Million USD | -1065.396% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -3979.052% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -11633.155% |
| Zura Bio Limited | 21.29 Million USD | -1237.972% |
| Forte Biosciences, Inc. | 3.66 Million USD | -7670.895% |
| Elevation Oncology, Inc. | 34.28 Million USD | -730.993% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -3608.905% |
| Immunome, Inc. | 28.65 Million USD | -894.071% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -3317.068% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -1868.362% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -412.419% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -5744.912% |
| Altimmune, Inc. | 16.54 Million USD | -1622.272% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -387.351% |
| Rallybio Corporation | 9.43 Million USD | -2919.086% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -2136.817% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -2604.139% |
| Moolec Science SA | 13.94 Million USD | -1942.838% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -109224.476% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -138191.748% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -5323.206% |
| NeurAxis, Inc. | 1.91 Million USD | -14793.877% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 59.161% |
| Lumos Pharma, Inc. | 13.33 Million USD | -2036.661% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -1868.362% |
| 180 Life Sciences Corp. | 5.38 Million USD | -5188.1% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -278.962% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -1107.737% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1151.689% |
| Nutriband Inc. | 1.07 Million USD | -26304.299% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -1863.207% |
| argenx SE | 444.95 Million USD | 35.975% |
| Neurogene Inc. | 36.54 Million USD | -679.45% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | 28.413% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -11551.575% |
| CervoMed Inc. | 2.59 Million USD | -10874.914% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -497.861% |
| Sesen Bio, Inc. | 30.98 Million USD | -819.446% |
| AnaptysBio, Inc. | 364.28 Million USD | 21.797% |
| Design Therapeutics, Inc. | 11.95 Million USD | -2282.745% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -2145.987% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -631.815% |
| Achilles Therapeutics plc | 19.08 Million USD | -1392.539% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -5541.208% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -831.045% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | 29.006% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -777.286% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -2083.147% |
| Palisade Bio, Inc. | 2.73 Million USD | -10300.913% |
| Beam Therapeutics Inc. | 478.38 Million USD | 40.449% |
| AEON Biopharma, Inc. | 159.88 Million USD | -78.174% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -997.342% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -3647.342% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -45.542% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -48.331% |
| Athira Pharma, Inc. | 30.05 Million USD | -847.803% |
| Vaccinex, Inc. | 5.94 Million USD | -4694.362% |
| HCW Biologics Inc. | 15.05 Million USD | -1792.653% |
| XOMA Corporation | 145.58 Million USD | -95.687% |
| Nektar Therapeutics | 267.04 Million USD | -6.679% |
| Arvinas, Inc. | 644.6 Million USD | 55.805% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1506.49% |
| Merus N.V. | 102.15 Million USD | -178.882% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -94.657% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -199.496% |
| Rezolute, Inc. | 11.73 Million USD | -2327.825% |
| Clene Inc. | 38.95 Million USD | -631.383% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -9905.022% |
| BeyondSpring Inc. | 48.26 Million USD | -490.195% |
| Synlogic, Inc. | 32.89 Million USD | -766.031% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -1849.504% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -17334.578% |
| Peak Bio, Inc. | 20.75 Million USD | -1272.698% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -348.921% |
| Krystal Biotech, Inc. | 39.71 Million USD | -617.331% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | 24.363% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -186.114% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -65734.038% |
| MannKind Corporation | 721.36 Million USD | 60.508% |
| Ikena Oncology, Inc. | 22.33 Million USD | -1175.491% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -13556.807% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -177.689% |
| Gossamer Bio, Inc. | 249.14 Million USD | -14.343% |
| CohBar, Inc. | 1.03 Million USD | -27461.003% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -2565.179% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1395.595% |
| Legend Biotech Corporation | 589.93 Million USD | 51.71% |
| Mural Oncology plc | 37.92 Million USD | -651.11% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -114.784% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -12311.32% |
| Disc Medicine, Inc. | 22.87 Million USD | -1145.381% |
| Champions Oncology, Inc. | 28.03 Million USD | -916.162% |
| REGENXBIO Inc. | 262.22 Million USD | -8.639% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -8380.237% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -2172.866% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -2020.972% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -1243.461% |
| Vaxart, Inc. | 34.02 Million USD | -737.27% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -1297.211% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -898.466% |
| Cellectis S.A. | 249.57 Million USD | -14.146% |
| Longeveron Inc. | 5.33 Million USD | -5237.849% |
| Repare Therapeutics Inc. | 41.81 Million USD | -581.224% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 88.156% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -371.907% |
| Revolution Medicines, Inc. | 262.39 Million USD | -8.569% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -13420.693% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -3202.585% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -2314.041% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -1928.633% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -13144.119% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 94.468% |
| Denali Therapeutics Inc. | 122.96 Million USD | -131.68% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -5019.253% |
| Veru Inc. | 32.81 Million USD | -768.203% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -4047.343% |
| Cingulate Inc. | 10.36 Million USD | -2649.587% |
| Passage Bio, Inc. | 39.26 Million USD | -625.59% |
| Context Therapeutics Inc. | 4.19 Million USD | -6696.287% |
| Exicure, Inc. | 8.54 Million USD | -3232.331% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -865.436% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -2616.775% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -8.569% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -1192.505% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -74.789% |
| Nuvalent, Inc. | 31.82 Million USD | -795.205% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -4378.115% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -352.034% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -1482.672% |
| OmniAb, Inc. | 87.4 Million USD | -225.951% |
| Anew Medical, Inc. | 8.24 Million USD | -3356.539% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -644.026% |
| Lipocine Inc. | 2.63 Million USD | -10725.272% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -984.352% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -608.448% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -969.3% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -230.665% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -5174.597% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -244.28% |
| Ocugen, Inc. | 23.98 Million USD | -1087.846% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -513.875% |
| Q32 Bio Inc. | 233.12 Million USD | -22.199% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -3042.301% |
| Alumis Inc. Common Stock | 53.5 Million USD | -432.468% |
| Equillium, Inc. | 27.95 Million USD | -918.997% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -37.895% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -4963.052% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -4545.076% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -81.077% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -310.296% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -2756.179% |
| Dominari Holdings Inc. | 4.63 Million USD | -6046.3% |
| Edesa Biotech, Inc. | 1.84 Million USD | -15368.901% |
| vTv Therapeutics Inc. | 29.56 Million USD | -863.51% |
| Bio-Techne Corporation | 744.34 Million USD | 61.727% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -125.919% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | 17.295% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -602.11% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -883.807% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -208.446% |
| Nkarta, Inc. | 105.6 Million USD | -169.774% |
| BioCardia, Inc. | 4.59 Million USD | -6106.558% |
| Iterum Therapeutics plc | 32.66 Million USD | -772.209% |